Share
Medicine Status
Ranitidine 150 mg Oral Tablet
Pill Identifier
Contents
Explore
Search
Medicine Status
More
About Medicine Status
Copyright © 2020 MedicineStatus.com and Spring Launch Media LLC. All Rights Reserved.

All content on this website ("the Site") is the property of Spring Launch Media LLC. The collection and assembly of content on this Site are the exclusive property of Spring Launch Media LLC and are protected by copyright and other intellectual property laws. MedicineStatus.com does not provide medical advice, diagnosis, or treatment, and urges you to consult with a qualified medical provider for diagnosis, treatment, and for answers to your medical questions. MedicineStatus.com does not warrant or assume any legal liability or responsibility for the accuracy, completeness, or usefulness of any information disclosed. MedicineStatus.com does not assume any responsibility for any aspect of medical care administered based on the contents provided on this Site. The contents of MedicineStatus.com, such as text, images, graphics, or other material are solely for informational purposes. MedicineStatus.com does not recommend or endorse any specific provider, opinions, procedures, or other information on the Site. Rely on any information provided by MedicineStatus.com or displayed on this Site solely at your own risk. Consult a healthcare professional before taking any drug, choosing or changing any course of treatment.

Ranitidine 150 mg Oral Tablet

Pill Finder Wizard
Overview Ranitidine 150 mg Oral Tablet is a round shaped, orangetablet that is approximately 9 mm in size. It has one score and can be broken into two pieces.

It is imprinted with "IP" and "253" and is supplied by Avpak.
Drug Name Ranitidine
Dosage Form Tablet
Imprint(s) IP, 253
Pill Size 9 mm
Color
Shape
Score
DEA Schedule (Potential for Drug Abuse)
Drug Ingredients
Active Ingredient(s) Ranitidine Hydrochloride
Inactive Ingredient(s) Silicon Dioxide, Croscarmellose Sodium, Hypromelloses, Magnesium Stearate, Cellulose, Microcrystalline, Polydextrose, Titanium Dioxide, Triethyl Citrate, FD&C Yellow No. 6
Drug Codes
RxNorm Concept Unique Identifier 198,191
National Drug Code 502680692
Marketing Category ANDA
References
Supplier Avpak
References The data for Ranitidine 150 mg Oral Tablet was updated by the U.S National Library of Medicine on January 18, 2018.

  • U.S. National Library of Medicine. Accessed June 8, 2019. https://www.nlm.nih.gov
  • Drug Scheduling. United States Drug Enforcement Administration. Accessed June 8, 2019. https://www.dea.gov/drug-scheduling
  • Structured Product Labeling Resources. U.S. Food & Drug Administration. March 27, 2018. Accessed June 8, 2019. https://www.fda.gov/industry/fda-resources-data-standards/structured-product-labeling-resources
  • HL7 Reference Information Model. HL7 Interational. Accessed June 8, 2019. http://www.hl7.org/implement/standards/rim.cfm